Cargando…

Spectrum of toxicity due to pheniramine overuse in a COVID-19 patient. How much do we know?

Pheniramine maleate is an easily accessible, potent antihistaminic compound used for the treatment of various allergic conditions. It acts on histamine one (H(1)) receptors on the central nervous system (CNS) and the peripheral tissues. It is a safe drug in therapeutic doses. However, overdoses as i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamath, Sangita D., Upadhaya, Ajatshatru, Mehta, Neelam, Yadav, Prabhakar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041004/ https://www.ncbi.nlm.nih.gov/pubmed/36994041 http://dx.doi.org/10.4103/jfmpc.jfmpc_853_22

Ejemplares similares

Statin treatment in the elderly: how much do we know?
por: Rizzo, Manfredi, et al.
Publicado: (2013)

N-95 masks: how much do we know?
por: Bakshi, Satvinder Singh, et al.
Publicado: (2020)

Mobile phones in Africa: how much do we really know?
por: James, Jeffrey, et al.
Publicado: (2007)

Identity of tendon stem cells – how much do we know?
por: Lui, Pauline Po Yee
Publicado: (2013)

Psychrotrophic bacteria in milk: How much do we really know?
por: de Oliveira, Gislene B., et al.
Publicado: (2015)

The Physiology of Bone Pain. How Much Do We Really Know?
por: Nencini, Sara, et al.
Publicado: (2016)

A Case Report of Cyanosis With Refractory Hypoxemia: Is It Methemoglobinemia?
por: Kamath, Sangita D, et al.
Publicado: (2022)

Rare Presentations of Sarcoidosis: A Case Series
por: Kamath, Sangita D, et al.
Publicado: (2023)

Pheniramine Maleate-Induced Rhabdomyolysis and Aki: Is it Fatal?
por: Venugopal, K, et al.
Publicado: (2014)

Disseminated Intravascular Coagulation Manifesting as Diffuse Alveolar Hemorrhage in a Scrub Typhus Patient: A Rarely Thought of Complication
por: Pandey, Mayank, et al.
Publicado: (2022)

Dairy Products and Metabolic Risk Factors: How Much Do We Know?
por: Wylie-Rosett, Judith
Publicado: (2011)

Zika Virus in a Patient With Cancer: How Much Do We Know?
por: Hepner, Adriana, et al.
Publicado: (2016)

Traumatic acute extracranial cerebral herniation: How much do we know?
por: Hoz, Samer S., et al.
Publicado: (2021)

Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
por: Cheung, Alison, et al.
Publicado: (2022)

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016)

Psychiatric co-morbidity associated with pheniramine abuse and dependence
por: Pal, Hemraj, et al.
Publicado: (2005)

Effect of pheniramine maleate on reperfusion injury in brain tissue
por: Yürekli, Ismail, et al.
Publicado: (2013)

Do Physicians Know Too Much?
Publicado: (1898)

Pulmonary Arterial Hypertension (PAH) as the Initial Manifestation of Systematic Lupus Erythematosus (SLE): A Rare Presentation
por: Kamath, Sangita D, et al.
Publicado: (2023)

How much do we know about the coupling of G-proteins to serotonin receptors?
por: Giulietti, Matteo, et al.
Publicado: (2014)

Variability of Practice, Information Processing, and Decision Making—How Much Do We Know?
por: Czyż, Stanisław H.
Publicado: (2021)

Metal-Based Anticancer Complexes and p53: How Much Do We Know?
por: Alfadul, Samah Mutasim, et al.
Publicado: (2023)

Preparation and Evaluation of Orodispersible Tablets of Pheniramine Maleate by Effervescent Method
por: Swamy, P. V., et al.
Publicado: (2009)

Knowing Too Much
Publicado: (1887)

How Much They Know
Publicado: (1892)

Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?
por: Christen, Urs, et al.
Publicado: (2016)

How much, if anything, do we know about sperm chromosomes of Robertsonian translocation carriers?
por: Wiland, Ewa, et al.
Publicado: (2020)

Commentary: Variability of Practice, Information Processing, and Decision Making—How Much Do We Know?
por: Kim, Taewon, et al.
Publicado: (2021)

Mantle cell lymphoma patients in first relapse: we pretty much know what to do
por: Quaglia, Francesca Maria, et al.
Publicado: (2021)

SDAV, the Rat Coronavirus—How Much Do We Know about It in the Light of Potential Zoonoses
por: Bartak, Michalina, et al.
Publicado: (2021)

Recovery in water polo: how much do we have to know? A systematic review
por: Barrenetxea-Garcia, Josu, et al.
Publicado: (2022)

Limb blastema formation: How much do we know at a genetic and epigenetic level?
por: Min, Sangwon, et al.
Publicado: (2022)

Pheniramine Maleate is more effective than Lidocaine on Fentanyl Induced Cough
por: Ozmen, Ozgur, et al.
Publicado: (2016)

Effect of pheniramine maleate on rat skeletal muscle ischemia-reperfusion injury
por: Erol, Kubilay, et al.
Publicado: (2021)

Ventilation and air-conditioning systems in dental clinics and COVID-19: How much do we know?
por: Plaza-Ruiz, Sonia P., et al.
Publicado: (2021)

Impact of Equine and Camel Piroplasmosis in Egypt: How Much Do We Know about the Current Situation?
por: Elsawy, Bassma S. M., et al.
Publicado: (2023)

Infoglut: how too much information is changing the way we think and know
por: Andrejevic, Mark
Publicado: (2013)

Primary Fibrosarcoma of the Liver: We Don't Know Much: A Case Report
por: Ali, Sadaf, et al.
Publicado: (2008)

New Strategies for the Reduction of Uremic Toxins: How Much More We Know
por: Rocchetti, Maria Teresa
Publicado: (2021)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_87b0srfqvfqr1mdlc4f6oltjrm